Cargando…
Dendritic Cells Expressing MyD88 Molecule Are Necessary and Sufficient for CpG-Mediated Inhibition of IgE Production In Vivo
Elevated levels of immunoglobulin E (IgE) are associated with allergies and other immunological disorders. Sensitization with alum adjuvant favours IgE production while CpG-ODN adjuvant, a synthetic toll-like receptor 9 (TLR9) agonist, inhibits it. The cellular mechanisms underlying in vivo TLR regu...
Autores principales: | Alberca Custodio, Ricardo W., Mirotti, Luciana, Gomes, Eliane, Nunes, Fernanda P.B., S. Vieira, Raquel, Graça, Luís, R. Almeida, Rafael, S. Câmara, Niels O., Russo, Momtchilo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829343/ https://www.ncbi.nlm.nih.gov/pubmed/31569343 http://dx.doi.org/10.3390/cells8101165 |
Ejemplares similares
-
CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10
por: Mirotti, Luciana, et al.
Publicado: (2017) -
CpG-ODN Signaling via Dendritic Cells-Expressing MyD88, but Not IL-10, Inhibits Allergic Sensitization
por: Alberca, Ricardo Wesley, et al.
Publicado: (2021) -
Allergen-Specific Immunotherapy With Liposome Containing CpG-ODN in Murine Model of Asthma Relies on MyD88 Signaling in Dendritic Cells
por: Alberca-Custodio, Ricardo Wesley, et al.
Publicado: (2020) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
por: Luo, Wu, et al.
Publicado: (2022)